{"id":5760,"date":"2023-09-04T03:36:19","date_gmt":"2023-09-04T03:36:19","guid":{"rendered":"https:\/\/cm.vastapps.dev\/tcia-analysis-result\/luad-ct-survival\/"},"modified":"2023-09-13T12:09:15","modified_gmt":"2023-09-13T12:09:15","slug":"luad-ct-survival","status":"publish","type":"tcia_analysis_result","link":"https:\/\/cm.vastapps.dev\/tcia-analysis-result\/luad-ct-survival\/","title":{"rendered":"LUAD-CT-SURVIVAL"},"featured_media":0,"template":"","cancer_types":["Lung Adenocarcinoma"],"citations":[4765,4766,4767,2925],"full_export":"

Summary<\/h2>

The dataset consists of pre-surgical chest CT images of 40 subjects from the H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida. The CT images were acquired by standard-of-care, contrast-enhanced CT scans among patients who had non-small cell cancer with biopsy-verified adenocarcinoma with 2 years of follow-up. A region-growing algorithm segmented the tumor with seed points that were chosen by radiologists.<\/p>

The adenocarcinoma cases are divided into the upper and lower quartiles of survival. Both the lower and upper quartiles have 20 cases. The lower quartile survival timeline is 103 to 498 days while the upper quartile timeline is 1351 to 2163 days. The average survival of the lower and upper quartiles is 288 days and 1569 days respectively. The median survival for the lower and upper quartiles is 289 and 1551 days respectively. The overall mean survival time is 879 days and median survival time is 925 days. Three of these cases, QIN-LSC-0009, QIN-LSC-0014, and QIN-LSC-0064\u00a0appear in\u00a0<\/span> LungCT-Diagnosis<\/a> \u00a0collection, while the remaining 37 cases are from the\u00a0<\/span> QIN Lung CT<\/a> \u00a0collection.<\/span><\/p>

<\/p>